IP Library Patent Application 14606901
Patent Application
App. No. 14/606,901

Processes for the Preparation of Highly Pure Plasmid Compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/606,901
Abstract

The present disclosure generally relates to processes for preparing highly pure plasmid compositions. The processes generally involve treating a composition comprising plasmid DNA with a polypeptide to digest colanic acid. The treated plasmid DNA is then separated from the treated composition.

Claims (28)

1 . A process for the purification of a plasmid DNA, the process comprising:

treating an aqueous composition containing the plasmid DNA with an isolated polypeptide that digests at least one of colanic acid or endotoxin; and

separating the plasmid DNA from the aqueous composition.

2 . The process of claim 1 , wherein the aqueous composition is selected from at least one of a crude bacterial lysate, a partially purified bacterial lysate, and an aqueous solution containing extracted bacterial nucleic acid.

3 . The process of claim 1 , wherein the separation comprises combining the treated aqueous composition with a chromatographic material.

4 . The process of claim 3 , wherein the chromatographic material is selected from at least one of an anion exchange chromatography resin, a cation exchange chromatography resin, a quaternary ammonium resin, a hydrophobic interaction chromatography resin, or an affinity chromatography resin.

5 . The process of claim 4 , wherein the separation comprises combining the treated aqueous composition with an affinity chromatography resin, and thereafter combining the treated aqueous composition with a hydrophobic interaction chromatography resin.

6 . The process of claim 1 , wherein the aqueous composition is pre-treated to partially remove endotoxin from the aqueous composition prior to treatment with the polypeptide, the pre-treatment comprising combining the aqueous composition with a chromatographic material.

7 . The process of claim 5 , wherein the affinity chromatography resin comprises a boronic acid-based or boronate-containing compound.

8 . The process of claim 1 , further comprising filtering the aqueous composition to further separate the endotoxin from the plasmid DNA.

9 . The process of claim 8 , wherein the filtering is performed after eluting the treated aqueous composition from the chromatography material.

10 . The process of claim 1 , wherein the polypeptide is a recombinant polypeptide.

11 . The process of claim 1 , wherein the aqueous composition is pre-treated to partially remove endotoxin from the aqueous composition prior to treatment with the polypeptide, the pre-treatment comprising combining the aqueous composition with a chromatographic material; combined with an affinity chromatography resin after treatment with the polypeptide, and thereafter combined with a hydrophobic interaction chromatography resin; and filtered to further separate endotoxin from the plasmid DNA after eluting the plasmid DNA from the hydrophobic interaction chromatography resin.

12 . The process of claim 1 , wherein the polypeptide comprises an amino acid sequence having at least 90% homology to SEQ ID NO: 1 or SEQ ID NO: 2, and conservative amino acid substitutions thereof.

13 . The process of claim 1 , wherein the polypeptide comprises an amino acid sequence having at least 98% homology to SEQ ID NO: 1 or SEQ ID NO: 2, and conservative amino acid substitutions thereof.

14 . The process of claim 1 , wherein the polypeptide is SEQ ID NO: 1 or SEQ ID NO: 2.

15 . The process of claim 1 , wherein the plasmid DNA is a gram-negative bacterial plasmid DNA.

16 . A process for the purification of plasmid DNA, the process comprising:

(a) pre-treating an aqueous composition containing plasmid DNA by combining the aqueous composition with an anion exchange resin;

(b) treating the pre-treated aqueous composition with an isolated polypeptide that digests at least one of colanic acid or endotoxin;

(c) separating the plasmid DNA from the aqueous composition, the separation comprising combining the treated aqueous composition with an affinity chromatography resin, and thereafter combining the treated aqueous composition with a hydrophobic interaction chromatography resin; and

(d) filtering the plasmid DNA.

17 . The process of claim 16 , wherein the anion exchange resin comprises a quaternary ammonium resin.

18 . The process of claim 16 , wherein the affinity chromatography resin comprises a boronic acid-based or boronate-containing compound.

19 . The process of claim 16 , wherein the polypeptide comprises an amino acid sequence having at least 90% homology to SEQ ID NO: 1 or SEQ ID NO: 2, and conservative amino acid substitutions thereof.

20 . The process of claim 16 , wherein the polypeptide comprises an amino acid sequence having at least 98% homology to SEQ ID NO: 1 or SEQ ID NO: 2, and conservative amino acid substitutions thereof.

21 . The process of claim 16 , wherein the plasmid DNA is a gram negative bacterial plasmid DNA.

22 . The process of claim 16 , wherein the polypeptide is a recombinant polypeptide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2015
From: TEMPLETON, NANCY SMYTH
To: GRADALIS, INC.
Reel/Frame 035140/0291 →